Login to Your Account



YL Biologics bringing CJ Healthcare’s biosimilar darbepoetin alfa to Japan

By David Ho
Staff Writer

Thursday, October 12, 2017

HONG KONG – YL Biologics Ltd. has inked a licensing deal to distribute a biosimilar for the treatment of anemia by Korea’s CJ Healthcare Ltd. in Japan.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription